← Back to Search

Behavioural Intervention

Peer Partnerships for Methamphetamine-Associated Heart Failure (PEER-Heart Trial)

N/A
Recruiting
Led By Brian Chan, MD, MPH
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No client-reported diagnosis of heart failure
Age 18 years or older
Must not have
Actively taking medications for heart failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

"This trial aims to test if training community members to screen for heart problems caused by methamphetamine use in rural areas is possible and effective in helping people get the right medical care."

Who is the study for?
This trial is for individuals in rural areas who use methamphetamine and may have heart failure linked to drug use. They should be willing to undergo screening and follow-up care via telehealth with a cardiology specialist.
What is being tested?
The study is testing if having community peers help with screening for heart issues caused by methamphetamine, plus getting cardiology care through telehealth, can work well in rural settings.
What are the potential side effects?
Since the interventions involve standard treatment and remote health services rather than medications, there are no direct side effects like you'd expect from drugs. However, participants might experience technical difficulties or privacy concerns with telehealth.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never been diagnosed with heart failure.
Select...
I am 18 years old or older.
Select...
I may have heart issues related to methamphetamine use, indicated by specific heart tests.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently on medication for heart failure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Linkage to cardiology care
Secondary outcome measures
Goal Directed Medical Therapy (GDMT) prescribed
Linkage to diagnostic echocardiogram

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer-Supported Telehealth CardiologyExperimental Treatment1 Intervention
Participants will receive a virtual consultation with a cardiovascular specialist, referral for a locally performed echocardiogram (ECG), and transitional care management facilitated by a remote nurse care manager and the peer to treat the participants heart failure.
Group II: Peer-supported Treatment as UsualActive Control1 Intervention
Participants will receive a peer-supported referral to a local primary care provider who will create a plan to treat the participants heart failure.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
994 Previous Clinical Trials
7,386,748 Total Patients Enrolled
8 Trials studying Heart Failure
4,867 Patients Enrolled for Heart Failure
University of WashingtonOTHER
1,791 Previous Clinical Trials
1,905,306 Total Patients Enrolled
18 Trials studying Heart Failure
19,582 Patients Enrolled for Heart Failure
Bay Area First StepUNKNOWN
~133 spots leftby Jun 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top